PubMed=1747867; DOI=10.1016/0165-4608(91)90359-3
Karnes P.S., Tran T.N., Cui M.Y., Bogenmann E., Shimada H., Ying K.L.
Establishment of a rhabdoid tumor cell line with a specific chromosomal abnormality, 46,XY,t(11;22)(p15.5;q11.23).
Cancer Genet. Cytogenet. 56:31-38(1991)

PubMed=8385567; DOI=10.1002/1097-0142(19930501)71:9<2862::AID-CNCR2820710930>3.0.CO;2-D
Ota S., Crabbe D.C.G., Tran T.N., Triche T.J., Shimada H.
Malignant rhabdoid tumor. A study with two established cell lines.
Cancer 71:2862-2872(1993)

PubMed=11557780; DOI=10.1038/modpathol.3880401
Itakura E., Tamiya S., Morita K., Shiratsuchi H., Kinoshita Y., Oshiro Y., Oda Y., Ohta S., Furue M., Tsuneyoshi M.
Subcellular distribution of cytokeratin and vimentin in malignant rhabdoid tumor: three-dimensional imaging with confocal laser scanning microscopy and double immunofluorescence.
Mod. Pathol. 14:854-861(2001)

PubMed=12210830; DOI=10.1002/jnr.10330
Yoshida S., Narita T., Taga T., Ohta S., Takeuchi Y.
Malignant rhabdoid tumor shows incomplete neural characteristics as revealed by expression of SNARE complex.
J. Neurosci. Res. 69:642-652(2002)

PubMed=16557275; DOI=10.1038/modpathol.3800599
Izumi T., Oda Y., Hasegawa T., Nakanishi Y., Iwasaki H., Sonobe H., Goto H., Kusakabe H., Takahira T., Kobayashi C., Kawaguchi K.-I., Saito T., Yamamoto H., Tamiya S., Iwamoto Y., Tsuneyoshi M.
Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Mod. Pathol. 19:820-831(2006)

PubMed=24418192; DOI=10.1111/cas.12352
Takita J., Chen Y., Kato M., Ohki K., Sato Y., Ohta S., Sugita K., Nishimura R., Hoshino N., Seki M., Sanada M., Oka A., Hayashi Y., Ogawa S.
Genome-wide approach to identify second gene targets for malignant rhabdoid tumors using high-density oligonucleotide microarrays.
Cancer Sci. 105:258-264(2014)

PubMed=31068700; DOI=10.1038/s41586-019-1186-3
Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. III, Barretina J., Gelfand E.T., Bielski C.M., Li H., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Nature 569:503-508(2019)